These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23723555)

  • 21. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
    Potkin SG; Litman RE; Torres R; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iloperidone: A new drug for the treatment of schizophrenia.
    Arif SA; Mitchell MM
    Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
    Citrome L; Weiden PJ; Alva G; Glick ID; Jackson R; Mattingly G; Kianifard F; Meng X; Winseck A
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):183-95. PubMed ID: 25367165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
    Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA
    Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iloperidone: a new option for the treatment of schizophrenia.
    Cutler AJ
    Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of risperidone on prolactinoma--a case report.
    Mendhekar DN; Jiloha RC; Srivastava PK
    Pharmacopsychiatry; 2004 Jan; 37(1):41-2. PubMed ID: 14750048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of galactorrhea associated with excitalopram.
    Shim SH; Lee YJ; Lee EC
    Psychiatry Investig; 2009 Sep; 6(3):230-2. PubMed ID: 20046401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pharmacogenetic studies of iloperidone.
    Nnadi CU; Malhotra AK
    Per Med; 2008 Jul; 5(4):367-375. PubMed ID: 29783461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol.
    Atmaca M; Kuloglu M; Tezcan E; Canatan H; Gecici O
    Arch Med Res; 2002; 33(6):562-5. PubMed ID: 12505103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.
    Camkurt MA; Gülpamuk G; Fındiklı E; Elve R
    Clin Psychopharmacol Neurosci; 2017 May; 15(2):181-183. PubMed ID: 28449567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperprolactinemic galactorrhea in a patient with Hodgkin's disease and intense pruritus.
    Cooper DL; Gilliam AC; Perez MI
    South Med J; 1993 Jul; 86(7):829-31. PubMed ID: 8322094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone-induced polydipsia and polyphagia associated with galactorrhea, abdominal pain, and rapid weight gain in an adolescent Hispanic female.
    Afzal KI; Briones DF; DeVargas C
    CNS Spectr; 2007 Nov; 12(11):818-20. PubMed ID: 17984854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.